Concerning ovarian cancer, Kleinberg et al. reported that XIAP and survivin are up-regulated in, respectively, effusions and metastasis of ovarian cancers, and could be considered to be targets and predictors of the patient outcomes36. This evidence concerns the gene XIAP and ovarian carcinoma.